- 346
- 57 932
Practice Point Communications
United States
Приєднався 16 сер 2022
Practice Point Communications is a medical education company that exclusively partners with academic medical centers to design and develop certified continuing medical education for healthcare providers. Our company offers superior experience and relationships with leading healthcare providers in specialty therapeutic areas with complex educational needs. Our programs are needs-based driven, innovative, well-executed, and provide outcomes validating educational impact. Continue to explore our website to learn more about PPC.
What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma
What’s New Doc?: CAR T-cells in Multiple Myeloma, highlights key studies and publications from 2024 on the use of these agents in earlier lines of treatment. Dr. Mikhael details how approved and emerging CAR T cell agents in multiple myeloma will impact the treatment landscape and how to better integrate these agents to enable improved outcomes among patients.
Follow the link in our bio to earn FREE AMA, ABS or ANCC credit!
Follow the link in our bio to earn FREE AMA, ABS or ANCC credit!
Переглядів: 12
Відео
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal-Updates from ACR Convergence 2024
Переглядів 4715 годин тому
In this Conversations in IFN-y episode, emerging data from the 2024 ACR meeting is discussed, highlighting advancements in understanding genetic drivers, cytokine dynamics, and biomarkers like IL-18 and CXCL9 for improved diagnosis and monitoring. Expert insights explore new findings on liver and lung pathology in MAS, as well as updates on therapeutic innovations, including JAK inhibitors and ...
2024 Highlights and Hindsight in CLL: End of Year Updates
Переглядів 382 години тому
In Highlights and Hindsight in CLL, Dr. Matthew Davids describes the most significant ongoing studies and publications in CLL from 2024 and details their impact on the treatment continuum. This activity enables participants to stay updated on the most relevant breakthroughs and improve outcomes among patients. Click the link in our bio to earn FREE AMA, ABS or ANCC credit!
Clinical Clips in Acute Myeloid Leukemia: Key Updates and Breakthroughs from ASH 2024
Переглядів 122 години тому
This podcast Clinical Clip features a leading expert highlighting the latest advances in Acute Myeloid Leukemia(AML) treatments presented at the 66th ASH Annual Meeting and Exposition from December 7-10, 2024, in San Diego, CA. Launch Date: December 16, 2024 Release Date: December 16, 2024 Expiration Date: November 30, 2025 FACULTY Naval Daver, MD Director, Leukemia Research Alliance Program, P...
Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024
Переглядів 2612 годин тому
Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024, will focus on the most exciting abstracts in hemophilia A and B that would be impactful for improved patient care. Dr. Guy Young will discuss the utility of key new evidence on replacement and non-replacement therapy to overcome current limitations and enable improved outcomes among patients. Launch Date: December 12, 20...
Clinical Clips in Acute Myeloid Leukemia: Key Updates and Breakthroughs from ASH 2024
Переглядів 3914 годин тому
This video Clinical Clip features a leading expert highlighting the latest advances in Acute Myeloid Leukemia(AML) treatments presented at the 66th ASH Annual Meeting and Exposition from December 7-10, 2024, in San Diego, CA. Click the link in our bio to earn FREE AMA, ABS, ANCC or ACPE credit!
Methamphetamine-Associated Pulmonary Arterial Hypertension
Переглядів 7314 годин тому
Methamphetamine-associated pulmonary arterial hypertension (MA-PAH) is a serious and increasingly recognized subtype of pulmonary arterial hypertension linked to methamphetamine use. In this on-demand clinical snippet, Dr. Vijay Balasubramanian delves into the epidemiology, clinical characteristics, and hemodynamic challenges of MA-PAH. Click the link in our bio to complete a brief post-test/ev...
Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024
Переглядів 7614 годин тому
Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024, will focus on the most exciting abstracts in hemophilia A and B that would be impactful for improved patient care. Dr. Guy Young will discuss the utility of key new evidence on replacement and non-replacement therapy to overcome current limitations and enable improved outcomes among patients. Click the link in our bio to...
Episode 3 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights a...
Переглядів 44День тому
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, an...
Episode 2 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights a...
Переглядів 17День тому
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, an...
Episode 1 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights a...
Переглядів 14День тому
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP inhibitors, an...
Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical Strategies
Переглядів 2514 днів тому
Mini-Module 2 Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP ...
Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical Strategies
Переглядів 3314 днів тому
Mini-Module 3 Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP ...
Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical Strategies
Переглядів 3214 днів тому
Mini-Module 1 Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers. It affects younger women, women of African descent, and those with BRCA1 mutations. TNBC is highly complex, with distinct subtypes that may respond differently to treatments. Recent advancements include immunotherapies, androgen receptor inhibitors, platinum-based drugs, antibody-drug conjugates, PARP ...
Episode 3 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Primary HLH
Переглядів 1214 днів тому
This third podcast episode in the series explores advanced understanding of primary hemophagocytic lymphohistiocytosis (HLH), focusing on its genetic basis, diagnostic innovations, and treatment strategies. The discussion highlights the pathophysiology of HLH as an interferon gamma (IFN-γ) driven disease, emphasizing the role of novel diagnostic tools such as flow cytometry and genetic panels. ...
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal: Primary HLH
Переглядів 3314 днів тому
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal: Primary HLH
Episode 2 - Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliar...
Переглядів 7021 день тому
Episode 2 - Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliar...
Episode 1 - Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliar...
Переглядів 3421 день тому
Episode 1 - Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliar...
Episode 2 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Diagnostic Factor...
Переглядів 2121 день тому
Episode 2 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Diagnostic Factor...
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal
Переглядів 2821 день тому
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal
Episode 2 - Ask the Expert: Emerging Evidence to Improve Outcomes in Vitiligo - Vitiligo: No Deci...
Переглядів 3821 день тому
Episode 2 - Ask the Expert: Emerging Evidence to Improve Outcomes in Vitiligo - Vitiligo: No Deci...
Episode 3 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Chall...
Переглядів 6321 день тому
Episode 3 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Chall...
Clinical Clips® From AASLD 2024 - Day 2
Переглядів 4221 день тому
Clinical Clips® From AASLD 2024 - Day 2
Clinical Clips® From AASLD 2024 - Day 1
Переглядів 6328 днів тому
Clinical Clips® From AASLD 2024 - Day 1
Talking PAH: Updates from the 7th World Symposium on Pulmonary Hypertension
Переглядів 7728 днів тому
Talking PAH: Updates from the 7th World Symposium on Pulmonary Hypertension
Talking PAH: Updates from the 7th World Symposium on Pulmonary Hypertension
Переглядів 17628 днів тому
Talking PAH: Updates from the 7th World Symposium on Pulmonary Hypertension
Episode 1 - Conversations in IFN-y Driven Diseases Decoding the Gamma Signal - Overview of Gamma ...
Переглядів 4328 днів тому
Episode 1 - Conversations in IFN-y Driven Diseases Decoding the Gamma Signal - Overview of Gamma ...
Episode 2 - Clinical Clips® Spotlighting Hot Topics in HIV: Independent Coverage From HIV Drug Th...
Переглядів 3228 днів тому
Episode 2 - Clinical Clips® Spotlighting Hot Topics in HIV: Independent Coverage From HIV Drug Th...
Episode 1 - Clinical Clips® Spotlighting Hot Topics in HIV: Independent Coverage From HIV Drug Th...
Переглядів 1228 днів тому
Episode 1 - Clinical Clips® Spotlighting Hot Topics in HIV: Independent Coverage From HIV Drug Th...
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal
Переглядів 58Місяць тому
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal